Skip to main content
SpringerLink
Log in

Furifosmin: The road to the final four

  • Editorial
  • Published:
Journal of Nuclear Cardiology Aims and scope

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

References

  1. Woodbury DH. Food and Drug Administration involvement and approval in minisymposium “The Birth of a New Radiopharmaceutical.” J Nucl Cardiol 1995;2:62–5.

    Article  PubMed  CAS  Google Scholar 

  2. Hendel RC, Verani MS, Miller DD, et al. Diagnostic utility of tomographic myocardial perfusion imaging with technetium-99m furifosmin (Q12) compared with thallium-201: results of a phase III multicenter trial. J Nucl Cardiol (in press).

  3. Zaret BL, Rigo P, Wackers FJT, et al. Myocardial perfusion imaging with technetium-99m Tc-99m tetrofosmin: comparison to thallium-201 imaging and coronary angiography in a phase-III multicenter trial. Circulation 1995;91:313–9.

    PubMed  CAS  Google Scholar 

  4. Burns RJ, Iles S, Fung AY, Wright LM, Daigneault L. The Canadian exercise technetium-99m-labeled teboroxime singlephoton emission computed tomographic study. J Nucl Cardiol. 1995;2:117–25.

    PubMed  CAS  Google Scholar 

  5. Miller DD. The growing flood of technetium-99m myocardial perfusion agents: more water…or more mud. Circulation 1995; 91:555–8.

    PubMed  CAS  Google Scholar 

  6. Pohost GM, Zir LM, Moore RM, McKusick KA, Guiney TE, Beller GA. Differentiation of transiently ischemic from infarcted myocardium by serial imaging after a single dose of thallium-201. Circulation 1979;55:294–302.

    Google Scholar 

  7. Christian TF, Schwartz KS, Gibbons RJ. Determinants of infarct size in reperfusion therapy for acute myocardial infarction. Circulation 1992;86:81–90.

    PubMed  CAS  Google Scholar 

  8. Heo J, Kegel J, Iskandrian AS, Cave V, Iskandrian BB. Comparison of same day protocols using technetium-99m-sestamibi myocardial imaging. J Nucl Med 1992;33:186–91.

    PubMed  CAS  Google Scholar 

  9. Berman DS, Kiat H, Maddahi J. The new 99m-Tc, myocardial perfusion imaging agents: 99m-Tc-sestamibi and 99m-Tc-teboroxime. Circulation 1991;84:17–21.

    Google Scholar 

  10. Taillefer R, Primeau M, Costi P, Lamber R, Leveille J, Latour Y. Technetium-99m sestamibi myocardial perfusion imaging in detection of coronary artery disease: comparison between initial (1-hr) and delayed (3-hr) postexercise images. J Nucl Med 1991; 32:1961–5.

    PubMed  CAS  Google Scholar 

  11. Chua T, Kiat H, Germano G, et al. Gated technetium-99m sestamibi for simultaneous assessment of stress myocardial perfusion, post-exercise regional ventricular function and myocardial viability: correlation with echocardiography and rest thallium-201 scintigraphy. J Am Coll Cardiol 1994;23:1104–11.

    Article  Google Scholar 

  12. Sinusas AJ, Trautman KA, Bergin JD, et al. Quantification of area at risk during coronary occlusion and degree of myocardial salvage after reperfusion with technetium-99m-methoxyisobutyl isonitrile. Circulation 1990;82:1424–37.

    PubMed  CAS  Google Scholar 

  13. O'Connor MK, Hammell TC, Gibbons RJ. In vitro validation of a simple tomographic technique for estimation of percent myocardium “at risk” following administration of Tc-99m isonitrile. Eur J Nucl Med 1990;17:69–76.

    Article  PubMed  Google Scholar 

  14. Glover DK, Ruiz M, Edwards NC, et al. Comparison between thallium-201 and technetium-99m sestamibi uptake during adenosine-induced vasodilation as a function of coronary stenosis severity. Circulation 1995;91:813–20.

    PubMed  CAS  Google Scholar 

  15. Gerson MC, Millard RW, Rosznell NJ, et al. Kinetic properties of Tc-99m Q12 in canine myocardium. Circulation 1994;89:1291–300.

    PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Medical College of Pennsylyania and Hahnemann University, 230 N Broad St., 19102, Philadelphia, PA

    Abdulmassih S. Iskandrian

Authors
  1. Abdulmassih S. Iskandrian
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

About this article

Cite this article

Iskandrian, A.S. Furifosmin: The road to the final four. J Nucl Cardiol 3, 356–357 (1996). https://doi.org/10.1016/S1071-3581(96)90097-5

Download citation

  • Issue Date:

  • DOI: https://doi.org/10.1016/S1071-3581(96)90097-5

Search

Navigation